Get a glimpse into our company and investor data—powered by the PitchBook Platform
Accelerator/IncLATEST DEAL TYPE
$100KLATEST DEAL AMOUNT
Developer of endothelin-1 traps. The company develops endothelin-1 traps which are antibody-based fusion proteins that could bind and sequester the increased levels of endothelin-1 found in different diseases.